The treatment of lung cancer has changed rapidly over the last few years and now more
than ever a multi-disciplinary approach is vital to patient care. Surgical resection remains the …

Lung cancer remains the leading cause of cancer-related deaths among men and women in
the civilized world. Although there have been major improvements over the recent decades …

Lung cancer is the leading cause of cancer deaths, and approximately 85% of patients in
whom this neoplasm is diagnosed will die of this disease as a result of micrometastatic …

In the United States, lung cancer kills more men and woman than the next three most
common cancers combined. Unfortunately, the long-term outcome of lung cancer is still …

Non-small-cell lung cancer (NSCLC) accounts for approximately 80% of all lung tumors.
Patients diagnosed with early-stage disease generally undergo surgery, but up to 50 …

Background Non-small cell lung cancer can no longer be regarded as resistant to
chemotherapy, and there have recently been considerable improvements in the use of the …

Though surgery offers the best chance of cure for patients with non-small cell lung cancer
(NSCLC), many patients who undergo complete tumor resection will die of recurrent …

Lung cancer remains the most common fatal malignancy, so even modest therapeutic
advances are potentially beneficial to large numbers of patients. For patients with regional …

Lung cancer remains the most common cause of cancer-related death among men and
women worldwide. Incremental and significant advances in available systemic treatments …

Lung cancer is a major health problem worldwide. Non-small-cell lung cancer (NSCLC)
accounts for 80% to 85% of all lung cancers, while small-cell lung cancer (SCLC) accounts …